Correction to Lancet Diabetes Endocrinol 2016; 4: 233–43 (The Lancet Diabetes and Endocrinology (2016) 4(3) (233–243)(S2213858715004891)(10.1016/S2213-8587(15)00489-1));Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: A randomised crossover trial

The Lancet Diabetes and Endocrinology

Volumn 4, Issue 3, 2016, Pages 233-243

  Russell, Steven J ^a   Hillard, Mallory A ^a   Balliro, Courtney ^a   Magyar, Kendra L ^a   Selagamsetty, Rajendranath ^b   Sinha, Manasi ^a   Grennan, Kerry ^a   Mondesir, Debbie ^a   Ehklaspour, Laya ^a   Zheng, Hui ^a   Damiano, Edward R ^b   El Khatib, Firas H ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; RECOMBINANT GLUCAGON; ANTIDIABETIC AGENT; GLUCAGON; GLUCOSE BLOOD LEVEL;

ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BODY MASS; CHILD; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTENTION TO TREAT ANALYSIS; MALE; MOBILE PHONE; NAUSEA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STOMACH DISCOMFORT; ADVERSE EFFECTS; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; INSULIN INFUSION; PHYSIOLOGIC MONITORING; TIME FACTOR; TREATMENT OUTCOME;

BLOOD GLUCOSE; CHILD; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MONITORING, PHYSIOLOGIC; PANCREAS, ARTIFICIAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84959557141     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(18)30053-6     Document Type: Erratum

References (29)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
2. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002, 287:2563-2594. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.
3. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005, 353:2643-2653.
4. Petitti DB, Klingensmith J, Bell RA, et al. Glycemic control in youth with diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr 2009, 155:668-672. for the SEARCH for Diabetes in Youth Study Group.
5. Tamborlane RW, Bergenstal RM, Miller KM, DuBose SN, Hall CA The T1D Exchange clinic registry. J Clin Endocrinol Metab 2012, 97:4383-4389. for the T1D Exchange Clinic Network.
6. Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange clinic registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 2013, 36:2035-2037. for the T1D Exchange Clinic Network.
7. Hypoglycemia in the diabetes control and complications trial. Diabetes 1997, 46:271-286. The Diabetes Control and Complications Trial Research Group.
8. Leese GP, Wang J, Broomhall J Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003, 26:1176-1180.
9. Cengiz E, Xing D, Wong JC, et al. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes 2013, 14:447-454. for the T1D Exchange Clinic Network.
10. Weinstock RS, Xing D, Maahs DM, et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab 2013, 98:3411-3419. for the T1D Exchange Clinic Network.
11. Cryer PE, Davis SN, Shamoon H Hypoglycemia in diabetes. Diabetes Care 2003, 26:1902-1912.
12. Russell SJ Progress of artificial pancreas devices towards clinical use: the first outpatient studies. Curr Opin Endocrinol Diabetes Obes 2015, 22:106-111.
13. Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 2014, 371:313-325.
14. Kovatchev BP, Renard E, Cobelli C, et al. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care 2014, 37:1789-1796.
15. Leelarathna L, Dellweg S, Mader JK, et al. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study. Diabetes Care 2014, 37:1931-1937.
16. van Bon AC, Luijf YM, Koebrugge R, et al. Feasibility of a portable bihormonal closed-loop system to control glucose excursions at home under free-living conditions for 48 hours. Diabetes Technol Ther 2014, 16:131-136.
17. Ly TT, Roy A, Grosman B, et al. Day and night closed-loop control using the integrated Medtronic hybrid closed-loop system in type 1 diabetes at diabetes camp. Diabetes Care 2015, 38:1-8.
18. Dexcom G4 Platinum user's guide Dexcom, (accessed April 1, 2014). http://www.dexcom.com/sites/dexcom.com/files/dexcom-g4-platinum/ifu/dexcom-g4-platinum-ifu.pdf.
19. El-Khatib FH, Russell SJ, Magyar KL, et al. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab 2014, 99:1701-1711.
20. Standard of medical care in diabetes. Diabetes Care 2013, 36(suppl 1):S11-S66. American Diabetes Association.
21. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ Translating the A1C assay into estimated average glucose values. Diabetes Care 2008, 31:1473-1478. for the A1c-Derived Average Glucose Study Group.
22. O'Riordan SM, Danne T, Hanas R, Peters CJ, Hindmarsh P Paediatric estimated average glucose in children with type 1 diabetes. Diabet Med 2014, 31:36-39.
23. Molnar GD, Taylor WF, Ho MM Day-to-day variation of continuously monitored glycaemia: a further measure of diabetic instability. Diabetologia 1972, 8:342-348.
24. Service FJ, Nelson RL Characteristics of glycemic stability. Diabetes Care 1980, 3:58-62.
25. Cryer PE Hypoglycemia begets hypoglycemia in IDDM. Diabetes 1993, 42:1691-1693.
26. Garg SK, Brazg RL, Bailey TS, et al. Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study. Diabetes Technol Ther 2014, 16:125-130.
27. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010, 2:27ra27.
28. Russell SJ, El-Khatib FH, Nathan DM, Magyar KL, Jiang J, Damiano ER Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care 2012, 11:2148-2155.
29. Cersosima E, Cummins MJ, Kinzell JH, et al. A phase 2 comparative safety PK/PD study of stable non-aqueous glucagon (g-Pen) vs Lilly glucagon for treatment of severe hypoglycemia. Diabetes 2014, 63(suppl 1A):1-LB.